Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1980 1
1981 2
1982 7
1984 2
1985 2
1986 4
1989 2
1990 1
1991 4
1992 4
1993 4
1994 2
1995 4
1996 3
1998 2
1999 1
2000 9
2001 9
2002 6
2003 2
2004 7
2005 4
2006 5
2007 5
2008 5
2009 2
2010 2
2011 2
2013 2
2014 1
2017 2
2018 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
The role of caveolin-1 in prostate cancer: clinical implications.
Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K, Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C, Goltsov A, Park S. Thompson TC, et al. Among authors: kadmon d. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):6-11. doi: 10.1038/pcan.2009.29. Epub 2009 Jul 7. Prostate Cancer Prostatic Dis. 2010. PMID: 19581923 Free PMC article. Review.
Gene therapy for prostate cancer.
Gdor Y, Timme TL, Miles BJ, Kadmon D, Thompson TC. Gdor Y, et al. Among authors: kadmon d. Expert Rev Anticancer Ther. 2002 Jun;2(3):309-21. doi: 10.1586/14737140.2.3.309. Expert Rev Anticancer Ther. 2002. PMID: 12113054 Review.
Gene therapy for prostate cancer.
Shalev M, Thompson TC, Kadmon D, Ayala G, Kernen K, Miles BJ. Shalev M, et al. Among authors: kadmon d. Urology. 2001 Jan;57(1):8-16. doi: 10.1016/s0090-4295(00)00903-1. Urology. 2001. PMID: 11164134 Review. No abstract available.
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC. Li L, et al. Among authors: kadmon d. Prostate Cancer Prostatic Dis. 2005;8(2):108-18. doi: 10.1038/sj.pcan.4500776. Prostate Cancer Prostatic Dis. 2005. PMID: 15724144 Review.
Therapeutic targets for metastatic prostate cancer.
Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Timme TL, et al. Among authors: kadmon d. Curr Drug Targets. 2003 Apr;4(3):251-61. doi: 10.2174/1389450033491127. Curr Drug Targets. 2003. PMID: 12643475 Review.
Influence of the neural microenvironment on prostate cancer.
Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, Ragheb A, Frolov A, Michailidis G, Lee M, Kadmon D, Miles B, Smith C, Ittmann M, Rowley D, Sreekumar A, Creighton CJ, Ayala G. Coarfa C, et al. Among authors: kadmon d. Prostate. 2018 Feb;78(2):128-139. doi: 10.1002/pros.23454. Epub 2017 Nov 13. Prostate. 2018. PMID: 29131367 Free PMC article.
108 results